Of the ten postings in this batch, 10x Genomics is the most revealing because the framing itself is a tell. The pitch leads with "help our customers understand and eradicate Covid-19" and uses the word "urgently" — a word almost no senior engineering recruiter uses unless headcount approval just dropped from above. This posting is a pandemic-response hiring surge dressed in a careers page.

The stack: Java, Rust, and React. That trio is unusual and informative:

• Java signals an established backend — likely LIMS-style pipeline orchestration, sample tracking, and integration with sequencing instrument data. Java is the lingua franca of bioinformatics infrastructure (think Broad Institute's GATK).
• Rust is the interesting one. For a genomics company, Rust almost certainly means high-throughput data processing — single-cell sequencing produces enormous matrices, and Rust offers C-level performance with memory safety. Hiring Rust talent suggests they're rewriting hot paths, not just experimenting.
• React covers the customer-facing analysis dashboards where biologists explore their data.

The split across Frontend, Full Stack, and Platform roles — all senior — tells you they have a working product and need to scale it under load, not greenfield it. Platform engineers in particular get hired when infrastructure pain has become bottleneck pain.

Green flags:

• Concrete mission tied to a real, measurable problem (Covid-19 research workflows).
• Remote work explicitly offered — meaningful in early-to-mid 2020 when many biotechs still required onsite.
• A real human contact (christine.eckhaus@) instead of a black-hole applicant portal.
• Senior-only roles signal they have the budget and the need for autonomous operators, not bootcamp-fillers.

Red flags:

• "Urgently searching" can mean attrition, not just growth. Worth probing in the interview: "What happened to the team that previously owned this work?"
• The pitch leans hard on Covid framing, but 10x Genomics' core business is single-cell genomics broadly. Candidates motivated purely by pandemic response may find themselves on roadmaps that long outlive the news cycle.
• No mention of compensation bands, equity structure, or team size — standard for the era but still a data gap.

The deeper signal: in March 2020, biotech infrastructure companies discovered they were suddenly critical infrastructure. The Java-plus-Rust stack tells you 10x Genomics is not a startup figuring out product-market fit — it's a scale-up rewriting its performance-critical paths because customer data volumes are outgrowing the original architecture.